Maxim Group analyst Jason McCarthy downgrades Aridis Pharmaceuticals (NASDAQ:ARDS) from Buy to Hold.
Shiba Inu ‘High Demand’ Drove SHIB’s Meteoric 46,000,000% Rise, Not Vitalik Buterin’s Token Burn, Says Data Tracker
Shibburn, a Shiba Inu (CRYPTO: SHIB) data tracker, addressed the misconception surrounding Ethereum (CRYPTO: ETH) co-creator Vitalik Buterin’s burn of $1.7 billion worth of